剂量反应关系依然存在且状况良好。 - Suppr

Dose-response is alive and well.

作者信息

DeVita V T

出版信息

J Clin Oncol. 1986 Aug;4(8):1157-9. doi: 10.1200/JCO.1986.4.8.1157.

DOI:10.1200/JCO.1986.4.8.1157

PMID:3525764

Abstract

摘要

相似文献

Dose-response is alive and well.

J Clin Oncol. 1986 Aug;4(8):1157-9. doi: 10.1200/JCO.1986.4.8.1157.

Dose intensity: a critique of a critical review.

J Clin Oncol. 1989 May;7(5):681-4. doi: 10.1200/JCO.1989.7.5.681.

Dose intensity in chemotherapy of metastatic breast cancer.

J Clin Oncol. 1985 Jun;3(6):889-91. doi: 10.1200/JCO.1985.3.6.889.

More is better.

J Clin Oncol. 1988 Sep;6(9):1365-7. doi: 10.1200/JCO.1988.6.9.1365.

Scientific misconduct in cancer clinical trials.

S Afr Med J. 2001 Aug;91(8):614-5.

Chemotherapy for advanced aggressive lymphoma: more is better ...isn't it?

J Clin Oncol. 1990 Jun;8(6):952-5. doi: 10.1200/JCO.1990.8.6.952.

[Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].

Rinsho Ketsueki. 2009 Apr;50(4):276-81.

[Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].

Acta Clin Belg Suppl. 1986;11:41-8.

Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.

J Clin Oncol. 1986 Mar;4(3):442-4. doi: 10.1200/JCO.1986.4.3.442.

[The use of high-dose chemotherapy in the treatment of breast cancer].

Med Clin (Barc). 1996 Jun 8;107(2):56-8.

引用本文的文献

Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells.

Int J Nanomedicine. 2012;7:789-98. doi: 10.2147/IJN.S28089. Epub 2012 Feb 14.

Magnetic Fe₃O₄ nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells.

Int J Nanomedicine. 2010 Nov 19;5:999-1004. doi: 10.2147/IJN.S14957.

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial.

Sarcoma. 2000;4(4):151-60. doi: 10.1155/2000/126837.

The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.

Drugs. 2000;60 Suppl 1:1-14; discussion 41-2. doi: 10.2165/00003495-200060001-00001.

Dose intensity analysis in advanced ovarian cancer patients.

Br J Cancer. 1993 Jan;67(1):190-7. doi: 10.1038/bjc.1993.33.

Optimizing the effectiveness of hematopoietic growth factors.

J Clin Immunol. 1994 Jul;14(4):215-23. doi: 10.1007/BF01552307.

Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Clin Pharmacokinet. 1987 Oct;13(4):205-27. doi: 10.2165/00003088-198713040-00001.

Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity.

Blut. 1988 Jun;56(6):241-8. doi: 10.1007/BF00320282.

Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.

Clin Pharmacokinet. 1989 Jun;16(6):327-36. doi: 10.2165/00003088-198916060-00001.

Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.

Med Oncol Tumor Pharmacother. 1989;6(3):207-12. doi: 10.1007/BF02985192.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Dose-response is alive and well.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献